Cargando…

Correction: potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis

Detalles Bibliográficos
Autores principales:	Mukherjee, Priyabrata, Bhattacharya, Resham, Bone, Nancy, Lee, Yean K, Patra, Chitta Ranjan, Wang, Shanfeng, Lu, Lichun, Secreto, Charla, Banerjee, Pataki C, Yaszemski, Michael J, Kay, Neil E, Mukhopadhyay, Debabrata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716828/ http://dx.doi.org/10.1186/1477-3155-11-23

Ejemplares similares

Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis
por: Mukherjee, Priyabrata, et al.
Publicado: (2007)

Inorganic phosphate nanorods are a novel fluorescent label in cell biology
por: Patra, Chitta Ranjan, et al.
Publicado: (2006)

Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells
por: Gannon, Christopher J, et al.
Publicado: (2008)

A core-shell nanomaterial with endogenous therapeutic and diagnostic functions
por: Patra, Chitta Ranjan, et al.
Publicado: (2010)

Cytotoxicity of naphthoquinones and their capacity to generate reactive oxygen species is quenched when conjugated with gold nanoparticles
por: Srinivas, Priya, et al.
Publicado: (2011)

Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*
por: Bhattacharya, Resham, et al.
Publicado: (2008)

Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine
por: Huai, Yanyan, et al.
Publicado: (2019)

Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles
por: Xiong, Xunhao, et al.
Publicado: (2014)

Experimental conditions influence the formation and composition of the corona around gold nanoparticles
por: Hossen, Md. Nazir, et al.
Publicado: (2021)

When the chains do not break: the role of USP10 in physiology and pathology
por: Bhattacharya, Udayan, et al.
Publicado: (2020)

Gold nanoparticles inhibit activation of cancer-associated fibroblasts by disrupting communication from tumor and microenvironmental cells
por: Zhang, Yushan, et al.
Publicado: (2020)

Biologically synthesized metal nanoparticles: recent advancement and future perspectives in cancer theranostics
por: Mukherjee, Sudip, et al.
Publicado: (2017)

Inhibiting the Growth of Pancreatic Adenocarcinoma In Vitro and In Vivo through Targeted Treatment with Designer Gold Nanotherapeutics
por: Kudgus, Rachel A., et al.
Publicado: (2013)

In Vitro Structural and Functional Evaluation of Gold Nanoparticles Conjugated Antibiotics
por: Saha, Biswarup, et al.
Publicado: (2007)

The neurotransmitter dopamine modulates vascular permeability in the endothelium
por: Bhattacharya, Resham, et al.
Publicado: (2008)

Potential Theranostics Application of Bio-Synthesized Silver Nanoparticles (4-in-1 System)
por: Mukherjee, Sudip, et al.
Publicado: (2014)

Biocompatible nickel-prussian blue@silver nanocomposites show potent antibacterial activities
por: Mukherjee, Sudip, et al.
Publicado: (2017)

Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo
por: Khan, Jameel Ahmad, et al.
Publicado: (2011)

BMI1, a new target of CK2α
por: Banerjee Mustafi, Soumyajit, et al.
Publicado: (2017)

Dynamic alteration of poroelastic attributes as determinant membrane nanorheology for endocytosis of organ specific targeted gold nanoparticles
por: Kulkarni, Tanmay, et al.
Publicado: (2022)

Small Non-Coding-RNA in Gynecological Malignancies
por: Dwivedi, Shailendra Kumar Dhar, et al.
Publicado: (2021)

Evaluation of I-TAC as a potential early plasma marker to differentiate between critical and non-critical COVID-19
por: Zhang, Yushan, et al.
Publicado: (2021)

Role of cystathionine beta synthase in lipid metabolism in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2015)

Cystathionine β-Synthase Is Necessary for Axis Development in Vivo
por: Prabhudesai, Shubhangi, et al.
Publicado: (2018)

Corrigendum: Cystathionine β-Synthase Is Necessary for Axis Development in vivo
por: Prabhudesai, Shubhangi, et al.
Publicado: (2018)

Multifunctional (3-in-1) cancer theranostics applications of hydroxyquinoline-appended polyfluorene nanoparticles
por: Chowdhury, Sayan Roy, et al.
Publicado: (2017)

The deubiquitinase USP10 protects pancreatic cancer cells from endoplasmic reticulum stress
por: Bhattacharya, Udayan, et al.
Publicado: (2022)

Biosynthesized Silver Nanoparticles for Cancer Therapy and In Vivo Bioimaging
por: Haque, Shagufta, et al.
Publicado: (2021)

Gold Nanoparticles Disrupt the IGFBP2/mTOR/PTEN Axis to Inhibit Ovarian Cancer Growth
por: Hossen, Md. Nazir, et al.
Publicado: (2022)

Targeting the TGFβ pathway in uterine carcinosarcoma
por: Dwivedi, Shailendra Kumar Dhar, et al.
Publicado: (2020)

Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro
por: Elechalawar, Chandra Kumar, et al.
Publicado: (2020)

Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance
por: Sinha, Sutapa, et al.
Publicado: (2021)

Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer
por: Wang, Enfeng, et al.
Publicado: (2011)

Switching the intracellular pathway and enhancing the therapeutic efficacy of small interfering RNA by auroliposome
por: Hossen, Md. Nazir, et al.
Publicado: (2020)

KRCC1, a modulator of the DNA damage response
por: Neizer-Ashun, Fiifi, et al.
Publicado: (2022)

Cystathione β-synthase regulates HIF-1α stability through persulfidation of PHD2
por: Dey, Anindya, et al.
Publicado: (2020)

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
por: Wang, Yucai, et al.
Publicado: (2021)

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy
por: Sinha, Sutapa, et al.
Publicado: (2018)

B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells
por: Wang, Zhiquan, et al.
Publicado: (2022)

Targeting BMI1 mitigates chemoresistance in ovarian cancer
por: Dey, Anindya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4kkcap5s4vl6jrge5coil49l0r